Whether or not to give adjuvant chemotherapy for breast cancer.
نویسندگان
چکیده
منابع مشابه
Whether or not to give adjuvant chemotherapy for breast cancer.
There is no longer any reasonable doubt that adjuvant chemotherapy prolongs survival for premenopausal women with early breast cancer. Indeed, in more than 100 years of research into breast cancer management it is the first form of treatment convincingly shown to have survival benefit. Yet important questions linger over its real clinical value. These include the balance of benefit against morb...
متن کاملEGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?
Epidermal growth factor receptor-tyrosine-kinase inhibitors (EGFR-TKIs) brought a significant revolution in the treatment of non-small-cell lung cancer (NSCLC). In a short period of time, EGFR-TKIs became the standard of treatment for mutation-positive, advanced stage non-squamous NSCLC. In recent years, second- and third-generation EGFR-TKIs are emerging, further widening the clinical use. How...
متن کاملAdjuvant chemotherapy for local relapse breast cancer.
Patients with isolated locoregional recurrences of breast cancer have a high risk of distant metastasis and death from cancer. The main objective in this clinical setting is curative treatment, which consists of radical surgery with or without complementary radiotherapy. The targeted localisations include soft tissue of the ipsilateral conserved breast or of the chest wall, mastectomy scar or s...
متن کامل[Neo-adjuvant chemotherapy for breast cancer].
OBJECTIVE To study the value and indications of a neo-adjuvant chemotherapy for breast cancers. METHODS Forty-three breast cancer patients were given the NF neo-adjuvant chemotherapy (Navelbine 25 mg/m2 and 5-Fu 500 mg/m2) for 3 cycles before the operation. Epirubicin (EPI 40 mg/m2) was added in patients with locally advanced lesions. G-CSF 75 micrograms subcutaneous injection was used to inc...
متن کامل[Adjuvant chemotherapy of early stage breast cancer].
UNLABELLED Adjuvant systemic therapy reduces the likelihood of both local and distant relapses by eradicating micrometastases. AIM To survey the adjuvant treatment of early breast cancer. METHODS Author presents an overview of the systemic therapy of early breast cancer based on relevant literature and own experiences. RESULTS Three systemic treatment modalities are widely used as adjuvan...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Postgraduate Medical Journal
سال: 1988
ISSN: 0032-5473
DOI: 10.1136/pgmj.64.758.937